Covid19_manual_annotation  

Documents (39) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
2020PubMed@AikoHIRAKI 33170884 Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of 3.52 KB 2021-06-11 1 102 2021-06-12
PubMed 33195060 Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting 1.6 KB 2021-06-09 4 93 2021-06-12
2020PubMed@AikoHIRAKI 33200028 Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-C 1.13 KB 2021-06-11 1 90 2021-06-11
PubMed 33213530 Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structure 6.58 KB 2021-01-17 15 354 2021-06-03
PubMed 33277105 Why does SARS-CoV-2 survive longer on plastic than on paper? The Covid-19 coronavirus, SARS-CoV-2, i 829 Bytes 2021-01-17 14 38 2021-06-08
PubMed 33501438 A comparative survey of Betacoronavirus binding dynamics relevant to the functional evolution of the 1.78 KB 2021-06-06 3 121 2021-06-12
PubMed 33576494 High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2. Heterol 1.65 KB 2021-06-09 5 142 2021-06-09
2020PubMed@AikoHIRAKI 33706041 Several independent datasets suggest blood type A is over-represented and type O under-represented a 1.66 KB 2021-06-10 1 60 2021-06-11
2020PubMed@AikoHIRAKI re32075365 [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. At th 1.25 KB 2021-06-10 1 95 2021-06-10
2020PubMed@AikoHIRAKI re32418532 Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SA 5.69 KB 2021-06-07 1 484 2021-06-07